論説
アレルギー性鼻炎に対する免疫療法の展望
2019 年 112 巻 3 号 p. 137-142
詳細
2019 年 112 巻 3 号 p. 137-142
Allergen immunotherapy, including subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT), has been evaluated as an effective and tolerable treatment for allergic rhinitis. Nowadays SLIT is widely employed for pollinosis in Japan, although its use in children and elderly patients is still restricted. Ipropose to conduct an analysis and confirm the efficacy and tolerability of this treatment modality in these age groups.
Moreover I introduced allergen immunotherapies in near future, monophosphoryl lipid A conjugated allergen immunotherapy, lysosomal associated membrane protein immunotherapy, and non-specific immunotherapy, anti-IgE immunotherapy. Allergen immunotherapy has the prospect of possibly becoming a curative treatment for allergic rhinitis.
